4/A//SEC Filing
Bohen Sean 4/A
Accession 0001415889-22-009915
CIK 0001750284other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 5:35 PM ET
Size
5.3 KB
Accession
0001415889-22-009915
Insider Transaction Report
Form 4/AAmended
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Common Stock
2022-09-21+20,000→ 74,279 total
Footnotes (3)
- [F1]This amendment is being filed solely to correct the transaction code in column 3 of Table I from code "A" to code "P".
- [F2]The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F3]Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831218
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 5:35 PM ET
- Size
- 5.3 KB